adenine has been researched along with trans-1,2-dihydro-1,2-naphthalenediol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Beijnen, JH; Rood, JJM; Schellens, JHM; Schinkel, AH; Sparidans, RW; van Hoppe, S | 1 |
Beijnen, JH; Dormans, PJA; Rood, JJM; Schellens, JHM; Sparidans, RW; van Haren, MJ | 1 |
Allal, B; Chatelut, E; De Barros, S; Despas, F; Dupré, L; Gallais, F; Obéric, L; Protin, C; Quillet-Mary, A; Thomas, F; White-Koning, M; Ysebaert, L | 1 |
Balogh, A; Bödör, C; Karvaly, GB; Köllő, Z; Vásárhelyi, B; Vincze, I | 1 |
4 other study(ies) available for adenine and trans-1,2-dihydro-1,2-naphthalenediol
Article | Year |
---|---|
Liquid chromatography-tandem mass spectrometric assay for the simultaneous determination of the irreversible BTK inhibitor ibrutinib and its dihydrodiol-metabolite in plasma and its application in mouse pharmacokinetic studies.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Chromatography, Liquid; Humans; Mice; Naphthalenes; Pilot Projects; Piperidines; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Tandem Mass Spectrometry | 2016 |
Bioanalysis of ibrutinib, and its dihydrodiol- and glutathione cycle metabolites by liquid chromatography-tandem mass spectrometry.
Topics: Adenine; Aged; Chromatography, Liquid; Drug Stability; Glutathione; Humans; Linear Models; Male; Naphthalenes; Piperidines; Pyrazoles; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2018 |
Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid Malignancies.
Topics: Adenine; Adult; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Naphthalenes; Piperidines | 2020 |
A High-Throughput Clinical Laboratory Methodology for the Therapeutic Monitoring of Ibrutinib and Dihydrodiol Ibrutinib.
Topics: Adenine; Humans; Laboratories, Clinical; Leukemia, Lymphocytic, Chronic, B-Cell; Naphthalenes; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines | 2022 |